Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 76 (RPL21P76) is a processed pseudogene related to the ribosomal protein L21 gene. Pseudogenes like RPL21P76 are DNA sequences that closely resemble known genes but have lost their protein-coding capability through evolutionary changes. RPL21P76 does not produce a functional protein and is not considered a therapeutic target, receptor, or enzyme. The parent gene, RPL21, encodes a protein that forms part of the 60S ribosomal subunit and is important for protein synthesis, but the pseudogene itself has no known biological function or role in disease[1][5]. If you need information about the functional ribosomal protein L21, not the pseudogene, that can be provided separately; for this entry (RPL21P76), it is non-functional[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 76 (RPL21P76).